Related Experiment Video
Updated: Nov 21, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Iron Sucrose: A Double-Edged Sword in High Phosphate Media-Induced Vascular Calcification
Ping Wang1, Chengkun Guo1, Hui Pan1
1Nephrology Department, The First People's Hospital of Jingmen, Jingmen, 448000, Hubei, China.
Insights
Iron sucrose (IS) can alleviate vascular calcification (VC) in high phosphate conditions but may cause iron overload at high concentrations. Further clinical studies are needed to determine optimal IS blood levels for patients with hyperphosphatemia.
Area of Science:
- Nephrology
- Biochemistry
- Cardiovascular Medicine
Background:
- Vascular calcification (VC) is prevalent in chronic kidney disease (CKD) patients.
- Hyperphosphatemia is a key driver of VC in CKD.
- The role of intravenous iron sucrose (IS) in VC is debated.
Purpose of the Study:
- To investigate the dual effects of IS on high phosphate-induced VC.
- To elucidate the mechanisms underlying IS interaction with VC.
Main Methods:
- Ex vivo culture of rat aortic rings with varying phosphate and IS concentrations.
- Measurement of calcium and iron deposition.
- Assessment of oxidative injury and gene expression.
Main Results:
- IS demonstrated a dose-dependent alleviation of VC.
- High IS concentrations led to significant iron deposition in vasculature.
- Oxidative stress markers and phenotypic gene expression were altered.
Conclusions:
- IS acts as a double-edged sword in high phosphate-induced VC.
- IS may be beneficial for VC prevention in hyperphosphatemic, iron-deficient CKD patients.
- Clinical research is required to establish safe and effective IS blood concentrations.
Abstract:
The high incidence of vascular calcification (VC) in patients with chronic kidney disease (CKD) has become an important clinical subject. Hyperphosphatemia is a primary cause of CKD-related VC. Intravenous iron sucrose (IS) is commonly used to treat anemia in CKD patients, and is effective and well tolerated worldwide. However, the interaction between iron and VC remains controversial, and the underlying mechanisms are yet to be clarified. In the present study, ex vivo normal rat aortic rings were cultured with various concentrations of phosphate and IS, and the levels of calcium and iron depositions, oxidative injury, as well as phenotypic marker genes were detected. To the best of our knowledge, the present study is the first to report that IS is a double-edged sword in high phosphate media-induced VC which not only alleviates VC in a dose-dependent manner but also leads to iron overload in vasculature when in high concentration. IS is a promising agent for VC prevention in patients with hyperphosphatemia and iron deficiency. Meanwhile, the appropriate blood concentration of IS in patients with hyperphosphatemia needs to be explored clinically.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Introduction to Electrolytes
Role of Sodium
One...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Factors Affecting Solubility

